TROP-2 overexpression in papillary renal cell carcinoma supports its potential as a therapeutic target for antibody-drug-conjugate therapy.
World journal of urology
View this publicationWorld journal of urology
View this publicationThe New England journal of medicine
View this publicationSeminars in perinatology
View this publicationJAMA cardiology
View this publicationNPJ systems biology and applications
View this publicationMovement disorders : official journal of the Movement Disorder Society
View this publicationEuropean heart journal
View this publicationJournal of leukocyte biology
View this publicationThe New England journal of medicine
View this publicationAllergy
View this publication